News
Boston Scientific joins Avicenna Alliance
As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to its list of members: Boston Scientific.
Meetings at US Senate Buildings
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
BMES conference – Frontiers in Medical Devices
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
Signature of Memorandum of Understanding with FDA !
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
Visit to the FDA
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine. The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
Avicenna Alliance in one year
Avicenna Alliance is proud to present its brochure showing the main achievements of the Alliance in one year.
